Latest News

Prolific: revolutionising the way the world learns about people

12th October 2023

All News | Spinouts & Startups | Startup Incubator

Pioneering a future of informed decisions: how Prolific is shaping the next wave of research and AI training with human-centric, quality data across the globe.

CEO Spotlight: Tony Coombs, Executive Chairman, Oxford VacMedix

12th October 2023

All News | Spinouts & Startups

For the latest in our CEO Spotlight series, we caught up with Dr Tony Coombs, Executive Chairman of Oxford VacMedix - a spinout company making waves in the world of cancer vaccines with its impressive pre-clinical and Phase 1 trial results.

Meet the winners of Oxford’s Jamie Ferguson Innovation Awards 2023

12th October 2023

All News | Partners | Spinouts & Startups

The second year of the Jamies Awards deliver ideas that tackle plastic waste, drug discovery, and bad coffee.

AI, genomics and frozen peas: Oxford’s thriving life sciences innovation scene

11th October 2023

All News | Spinouts & Startups

From supermarket peas to multi million-dollar deals: Oxford's biotech startups are rewriting the playbook on chronic inflammation, genomic mysteries, and the AI in medicine. Witness how audacious ideas, nurtured in humble settings, mature into world-changing medical innovations in an ecosystem where science, business, and global impact entwine.

University-led collaboration aims to supercharge UK Social Ventures

9th October 2023

All News | Financial News | Spinouts & Startups

Funding via the Connecting Capability Fund will provide acceleration of support for the UK university social venture sector.

CEO Spotlight: Frank Cheng, Caristo Diagnostics

14th June 2023

All News | Spinouts & Startups

Caristo's Frank Cheng speaks with OUI on transforming heart disease diagnostics, the evolution of Oxford, and the future of one of Oxford's most exciting companies.

Beacon Therapeutics launches with £96 million ($120 million) to develop a new generation of gene therapies for retinal diseases resulting in blindness

12th June 2023

All News | Financial News | Spinouts & Startups | Technology News

Professor Robert MacLaren's retinal gene therapy.

Beacon Therapeutics spun out by Syncona and Oxford raises £96 million for retinal gene therapy

12th June 2023

All News | Financial News | Spinouts & Startups | Technology News

Beacon Therapeutics, a pioneering new biotech company, has launched with a mission to restore and improve the vision of patients with retinal diseases. The company is one of the most ambitious spinouts the University has been involved in to date, starting out with an impressive £96 million ($118.5m) in funding, the biggest launch for any company including an Oxford spin-out programme.

Oxford Alumna and Cancer Survivor Launches New App to Support Cancer Patients

8th June 2023

All News | Spinouts & Startups | Startup Incubator

MBA Graduate Ani Hakyuni’s own experience surviving cancer inspires new startup.
The app, Vann, will create support groups for people battling cancer.
Vann will provide key insights to support clinician decision making in oncology.

OUI Incubator welcomes cohort six to Phase 2

24th May 2023

All News | Spinouts & Startups | Startup Incubator

Take a glimpse into the future with startups emerging from OUI’s incubator.

News

Ready to get in touch?